A Story
I once worked with a guy who I thought was a straight shooter. He and I were on night shift together for quite a long time. I never once had an occasion to think anything he ever told me wasn't factual. One night, he told me about a previous job he had held. He had been a security guard at Strong Memorial Hospital in Rochester, New York. Here's the story he told me.
One night, he had been called to the "R" wing of the hospital to deal with an escape. The R wing - I suppose they still call it that - was the psychiatric ward. A patient had gotten out of the secure wing but was still in the hospital. He had, in fact, been cornered in a room by staff members who had called security for assistance. My friend responded.
When he got to the location, he found that the escapee was inside a lab area with only one entrance. The staff were making sure he could not get out, but they needed a bit of help securing the man. My friend stepped into the room to see a man wearing just a robe. When my friend approached the man in the bathrobe, the man began to talk. As my friend told it, the man appeared to be completely lucid, not at all agitated and just asked to talk for a moment. The man told him that he had been a researcher at the cancer clinic at the hospital.
The man told my friend that he had discovered a cancer treatment that cost almost nothing and that was amazingly effective. When he tried to get the lab's supervisors interested, he had, instead of being proclaimed a hero, been bundled off to the R wing. He pleaded with my friend to help him. When the request was refused, the man became highly agitated. My friend had to subdue him by force. The staff came in an sedated him, then took the man back to the R wing.
My friend looked at me after telling me all this and said, "I don't know if he was telling the truth. But what is he was?"
So, here's a news item.
Edmonton, AB (AHN) - It is expected there would be no problems securing funding to explore a drug that could shrink cancerous tumors and has no side-effects in humans, but University of Alberta researcher Evangelos Michelakis has hit a stalemate with the private sector who would normally fund such a venture.
Michelakis' drug is none other than dichloroacetate (DCA), a drug which cannot be patented and costs pennies to make.
It's no wonder he can't secure the $400-600 million needed to conduct human trials with the medicine - the drug doesn't have the potential to make enough money.
Michelakis told reporters they will be applying to public agencies for funding, as pharmaceuticals are reluctant to pick up the drug.
At roughly $2 a dose, there isn't much chance to make a billion on the cancer treatment over the long term.
I suppose we ought to see if Michelakis ends up in a ward somewhere.







